Ventas (VTR) Akcija Kursas
Ventas Kursas
Pajamos augo 14,9 % per metus per pastaruosius 19 metus iki 5,83 mlrd. USD. Pelnas akcijai mažėjo 4,4 % per metus per pastaruosius 19 metus. Ventas grynoji marža dabar yra 4,3 %, išaugo nuo 1,3 % prieš kelerius metus. Ventas šiuo metu siūlo apie 2,15 % dividendo pajamingumą. Išmokų koeficientas yra apie 367 % pelno. Dividendas augo 1,0 % per metus per pastaruosius 19 metus. Analitikų tikslinės kainos mediana yra 99,00 USD, t. y. virš dabartinę kainą 11,0 %. Iš 27 analitikų 22 rekomenduoja pirkti — bendras konsensusas yra Pirkti.
Ventas akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Ventas akcija ir akcijų analizė
Dažnai užduodami klausimai apie Ventas akciją
Ventas Inc is a leading real estate investment trust (REIT) specializing in healthcare properties. The business model of Ventas Inc revolves around owning, operating, and acquiring a diversified portfolio of properties across the healthcare sector. Their primary focus is on leasing and managing healthcare facilities, including senior housing communities, medical offices, hospitals, and research centers. By providing essential real estate solutions to healthcare providers, Ventas Inc generates recurring rental income and long-term value for its shareholders. Through strategic investments and a commitment to innovation, Ventas Inc continues to contribute to the growth and development of the healthcare industry.
Ventas Inc is primarily active in the healthcare real estate sector.
Some of the main competitors of Ventas Inc in the market include Welltower Inc and HCP Inc.
Ventas Inc is a renowned company operating in the real estate investment trust (REIT) sector. Established in 1998 and headquartered in Chicago, Illinois, Ventas specializes in healthcare-related properties. They own and manage a diverse portfolio of premium healthcare facilities, including senior housing communities, medical office buildings, hospitals, and skilled nursing facilities. Ventas has played a pivotal role in transforming the healthcare real estate sector through its strategic acquisitions and investments. With a strong commitment to delivering exceptional care environments, Ventas Inc has become a leading name in the industry, offering investors an opportunity to participate in this thriving sector.
Some significant milestones achieved by Ventas Inc include becoming the first healthcare real estate investment trust (REIT) to be listed on the New York Stock Exchange in 1999. The company also expanded its portfolio through strategic acquisitions, such as the $7.2 billion merger with Nationwide Health Properties in 2011. Additionally, Ventas Inc consistently demonstrated strong financial performance, increasing its annual dividend for 19 consecutive years. The company's commitment to long-term growth and its focus on providing quality healthcare real estate solutions have made Ventas Inc a leader in the industry.
Ventas Inc is primarily present in the United States.
Ventas Inc represents a commitment to integrity, innovation, and excellence in the healthcare real estate industry. The company strives to enhance the lives of seniors and other patients by providing high-quality and transformative healthcare environments. With a focus on sustainable growth and generating long-term value for stakeholders, Ventas Inc employs a philosophy of collaboration, transparency, and ethical business practices. By consistently delivering innovative solutions and maintaining strong relationships with its tenants and partners, Ventas Inc continues to lead the way in the healthcare real estate sector.
Analitikai šiuo metu nustato vidutinę Ventas akcijos tikslinę kainą 98,85 USD (mediana: 99,00 USD), t. y. +10,8 % palyginti su paskutine kaina. Konsensusas pagrįstas 27 analitikų reitingais.
27 analitikai šiuo metu vertina Ventas akciją: 22 rekomenduoja pirkti, 5 laikyti ir 0 parduoti. 2026 m. analitikai tikisi, kad Ventas gaus 6,95 mlrd. USD pajamų ir 0,56 USD pelno akcijai.
Pagal dabartinį kursą Ventas akcija kainuoja 79,38 EUR (89,20 USD).
Ventas akcija (VTR) kotiruojama 7 biržose, įskaitant: NYSE (VTR), London (0LO4.L), SIX (Zürich) (VEN.SW), Frankfurt (VEN.F), München (VEN.MU), Düsseldorf (VEN.DU).
Ventas Inc is a US-based company specializing in healthcare real estate investments. Its business model is based on acquiring and managing properties used by healthcare and senior living facilities. The company is divided into three business segments: Senior Housing Operating Portfolio (SHOP), Medical Office Buildings (MOB), and Life Science Properties (LSP). SHOP includes a wide range of nursing homes and elderly care facilities. Ventas Inc acquires these properties either through facility purchases or by acquiring concession contracts from operators. The company directly operates approximately 110 facilities, making SHOP its highest revenue-generating segment. The MOB segment focuses on acquiring properties used by medical facilities such as doctor's offices, laboratories, and surgical centers. These facilities are often located in complex buildings or campus-like environments and often offer services such as pharmacies, radiology, and rehabilitation. LSP focuses on the real estate needs of life science companies, including biopharmaceutical, biotechnology, and diagnostic companies. The complexity of the properties developed for life science companies requires a high level of expertise and flexibility. Ventas Inc also provides financing and capital structures for the development or acquisition of properties in the SHOP, MOB, and LSP segments. These financing offerings can be tailored to the specific needs of facilities and operators and also include partnerships with other investors. Ventas Inc strives to ensure high-quality and continuous care for patients in its healthcare market through the provision of real estate and financing. The company also emphasizes a long-term growth strategy focused on strengthening operational performance and financial metrics. Overall, Ventas Inc's business model demonstrates a consistent focus on the increasingly important healthcare industry and the needs of patients. With a wide range of real estate offerings and financing options, the company is well-positioned to drive industry growth.
tikėtina pelnas Ventas yra 6,95 mlrd. USD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas Ventas yra 270,76 mln. USD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Ventas šiuo metu yra 158,38. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Ventas akcijos vertę.
Kainų ir pardavimų santykis (KUV) Ventas šiuo metu yra 6,17. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Ventas akcijos įvertinimo metrika.
Eulerpool kokybės balas Ventas yra 4/10.
Ventas ISIN yra US92276F1003. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Ventas WKN yra 878380. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Ventas prekybos žymė yra VTR. Ši biržos žymė naudojama Ventas akcijoms prekiauti biržoje.
Ventas akcija
Ventas Pagrindiniai konkurentai
Ventas Biržos simbolis
Ventas FIGI
Visos Ventas pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Ventas akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Ventas. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: